It refers to a combination, including (I) a cdr38 antigen component composed of SEQ ID No.18 and SEQ ID No.22 light chain CDR1, CDR2 and CDR3, which is combined with SEQ ID No.3, 5, 6, 7, 212 or 213 and (II) reduced α - 2b interference. This combination is useful in the treatment of tumors, such as multicellular tumors, B-cell lymphoma, and so on.
展开▼
机译：它是指一种组合，包括（I）由SEQ ID No.18和SEQ ID No.22轻链CDR1，CDR2和CDR3组成的cdr38抗原成分，与SEQ ID No.3、5、6、7组合，212或213和（II）减少了α-2b干扰。该组合可用于治疗肿瘤，例如多细胞肿瘤，B细胞淋巴瘤等。
展开▼
